Name: TScan Therapeutics, Inc. (TCRX) Balance Sheet
Creator: FinSpry

TScan Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for TScan Therapeutics, Inc. (TCRX) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Current Assets
Cash and Cash Equivalents	178.69	133.36	120.03	161.41	34.79
Short-Term Investments	111.42	58.69	0.00	0.00	0.00
Cash & Short-Term Investments	290.11	192.04	120.03	161.41	34.79
Accounts Receivable	0.00	0.00	0.00	0.00	0.00
Inventory	0.00	0.00	0.00	0.00	0.00
Other Current Assets	2.61	2.19	4.10	4.25	1.65
Total Current Assets	292.72	194.24	124.13	165.65	36.45
Non-Current Assets
Property, Plant & Equipment (Net)	71.60	71.23	69.20	17.26	12.53
Other Non-Current Assets	6.80	6.68	5.76	5.03	0.76
Total Non-Current Assets	78.40	77.91	74.96	22.45	0.00
Total Assets	371.12	272.15	199.09	188.11	49.74
Current Liabilities
Accounts Payable	4.28	2.37	2.91	8.28	2.91
Short-Term Debt	4.57	3.35	0.00	0.00	0.00
Current Portion of Long-Term Debt	0.00	3.35	0.00	0.00	0.00
Accrued Liabilities	15.33	4.81	6.41	2.91	2.36
Deferred Revenue	11.70	10.14	3.87	11.41	10.63
Other Current Liabilities	15.41	0.43	0.43	2.60	0.13
Total Current Liabilities	35.96	29.82	17.31	21.34	17.45
Non-Current Liabilities
Long-Term Debt	92.81	26.70	29.29	4.39	0.00
Other Non-Current Liabilities	0.14	0.00	0.05	0.10	0.24
Total Non-Current Liabilities	94.19	91.46	82.35	5.99	0.00
Total Liabilities	130.15	121.28	99.66	27.33	32.52
Stockholders' Equity
Common Stock	0.01	0.01	0.00	0.00	0.00
Retained Earnings	-375.10	-247.60	-158.38	-92.16	-43.53
Accumulated Other Comprehensive Income	0.05	0.00	0.00	0.00	0.00
Additional Paid-in Capital	616.01	398.46	257.81	252.93	0.00
Shares Outstanding	56.59	47.83	24.23	23.91	0.00
Total Stockholders' Equity	240.97	150.87	99.43	160.78	17.22
Total Liabilities & Equity	371.12	272.15	199.09	188.11	0.00